Comprehensive Blood Sugar Management with Trijardy XR
Trijardy XR 25mg/5mg/1000mg is a prescription medication used to improve glycemic control in adults with type 2 diabetes. It is a triple-combination therapy that brings together three powerful anti-diabetic agents—Empagliflozin, Linagliptin, and Metformin Hydrochloride Extended-Release—into a single, once-daily tablet.
For many Nigerians managing type 2 diabetes, Trijardy XR offers a simplified treatment regimen by reducing the daily pill burden.
How Trijardy XR Works
Each component of Trijardy XR targets blood sugar through a different mechanism:
- Empagliflozin (25mg): An SGLT2 inhibitor that works with your kidneys to help remove excess sugar from your body through urine. It is also clinically recognized for its cardiovascular benefits.
- Linagliptin (5mg): A DPP-4 inhibitor that boosts the levels of incretin hormones, which tell your pancreas to produce more insulin when your blood sugar is high.
- Metformin HCl XR (1000mg): A biguanide that reduces the amount of glucose produced by your liver and improves your body’s natural response to insulin.
Benefits of Triple-Combination Therapy
- Simplified Regimen: One tablet daily replaces the need for three separate medications.
- Heart Protection: Helps reduce the risk of cardiovascular death in adults with type 2 diabetes and heart disease.
- Steady Control: The extended-release (XR) formulation ensures a gradual release of medication throughout the day.
How to Take Trijardy XR
To achieve the best results and minimize potential stomach upset (commonly associated with metformin), it is recommended to take Trijardy XR once daily in the morning with a meal. The tablet must be swallowed whole; do not crush, chew, or break it.
If you have questions about side effects or how long it takes to work, you can contact a GoMed pharmacist for professional guidance.